APL-101-01 (SPARTA) | Maryland Oncology Hematology APL-101-01 (SPARTA) – Maryland Oncology Hematology

APL-101-01 (SPARTA)

Trial Information

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met Exon 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Sponsor: Apollomics, Inc.

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lung Cancer, Solid Tumors


Ali, Kashif


Apollomics, Inc.

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology